Scan
To download the app
Download the Beloud app and enjoy reading the latest news, freedom of speech, and connect with the like-minds.
Download on the
App Store
Download on the
Google Play

Continue reading in...


Beloud logo
Beloud App
Open
Safari
Continue
beloud logo
  • Sign in
    Saved
    Subscription
    Settings
For You
Headlines
NewsStand
For You
Headlines
NewsStand
Saved
Light/Dark
Invite friends
Settings
Support
Get the app
Seekingalpha
@seekingalpha.com · 1 hour

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis - Slideshow

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis - Slideshow
Apogee Therapeutics, Inc. (APGE) has released a slide deck detailing 52-week Phase 2 data for its drug Zumilokibart. The drug is being tested for moderate to severe atopic dermatitis. The da...
Read more Seekingalpha.com

Likes (0)
Dislikes (0)
Log in
  • Sign in
    Saved
    Subscription
    Settings
    CRM automation
Log In Or Sign Up
Sign Up Now To Get Your Own Personalized Timeline
Continue with Email
By signing up, you agreed to our Terms of used and Privacy policy, including Cookies use.
Terms of use
Privacy policy
Publishers
Contact
About us
Subscription
CRM automation
© 2022 Safe Apps